Prognosis of non-albuminuric patients with the cardiovascular–kidney–metabolic syndrome
The findings indicate that elevated UACR levels within the normal range are significantly associated with poor prognosis among CKM patients at stages 2 and 3. These results underscore the critical role of UACR in identifying high-risk populations, particularly among individuals with metabolic disorders. This information may prove valuable for monitoring and implementing risk intervention strategies for CKM patients.
Authors
- Feng Hua Ding (ORCID: https://orcid.org/0000-0002-7961-9695)
- Sheng Nie (ORCID: https://orcid.org/0000-0002-8267-7909)
- Xiao Bi (ORCID: https://orcid.org/0000-0001-5323-3404)
- Wenji Wang (ORCID: https://orcid.org/0009-0002-7805-0270)
- Yuqi Shen (ORCID: https://orcid.org/0009-0008-9114-8743)
- Shiyu Zhou (ORCID: https://orcid.org/0000-0002-6564-9666)
- Yue Shen (ORCID: https://orcid.org/0000-0002-5987-2415)
- Aiwen Shen
- Xuezhu Li (ORCID: https://orcid.org/0000-0002-7079-9140)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Ninth People's Hospital (CN)
- Nanfang Hospital (CN)
- National Clinical Research (US)
- Southern Medical University (CN)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1093/ckj/sfaf074
- Citations
- 3
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 4.29
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China